Page 81 - GPD-3-3

Gene & Protein in Disease Gene therapy progress for DEB

genome and transcriptome of living cells. Nat Rev Genet. retroviral vectors expressing COL7A1 under human
2018;19(12):770-788. promoters for ex vivo gene therapy of recessive dystrophic
epidermolysis bullosa. Mol Ther. 2010;18(8):1509-1518.
doi: 10.1038/s41576-018-0059-1
doi: 10.1038/mt.2010.91
78. Sheriff A, Guri I, Zebrowska P, et al. ABE8e adenine base
editor precisely and efficiently corrects a recurrent COL7A1 89. Siprashvili Z, Nguyen NT, Gorell ES, et al. Safety and
nonsense mutation. Sci Rep. 2022;12(1):19643. wound outcomes following genetically corrected autologous
epidermal grafts in patients with recessive dystrophic
doi: 10.1038/s41598-022-24184-8
epidermolysis bullosa. JAMA. 2016;316(17):1808.
79. Taha EA, Lee J, Hotta A. Delivery of CRISPR-Cas tools for doi: 10.1001/jama.2016.15588
in vivo genome editing therapy: Trends and challenges.
J Control Release. 2022;342:345-361. 90. Bruckner-Tuderman L, Guscetti F, Ehrensperger F. Animal
model for dermolytic mechanobullous disease: Sheep with
doi: 10.1016/j.jconrel.2022.01.013 recessive dystrophic epidermolysis bullosa Lack collagen
80. Anzalone AV, Koblan LW, Liu DR. Genome editing with VII. J Invest Dermatol. 1991;96(4):452-458.
CRISPR-Cas nucleases, base editors, transposases and prime doi: 10.1111/1523-1747.ep12470130
editors. Nat Biotechnol. 2020;38(7):824-844.
91. Pérez V, Benavides J, Delgado L, Reyes LE, García Marín JF,
doi: 10.1038/s41587-020-0561-9 Ferreras MC. Dystrophic epidermolysis bullosa in assaf
81. Anzalone AV, Randolph PB, Davis JR, et al. Search-and- lambs. J Comp Pathol. 2011;145(2-3):226-230.
replace genome editing without double-strand breaks or doi: 10.1016/j.jcpa.2010.12.002
donor DNA. Nature. 2019;576(7785):149-157.
92. White SD, Dunstan RW, Olivry T, Naydan DK, Richter K.
doi: 10.1038/s41586-019-1711-4 Dystrophic (dermolytic) epidermolysis bullosa in a cat. Vet
82. Steinbeck BJ, Gao XD, McElroy AN, et al. Twin prime editing Dermatol. 1993;4(2):91-95.
mediated exon skipping/reinsertion for restored collagen doi: 10.1111/j.1365-3164.1993.tb00197.x
VII expression in recessive dystrophic epidermolysis
bullosa. J Invest Dermatol. 2024:S0022202X24003725. 93. Palazzi X, Marchal T, Chabanne L, Spadafora A, Meneguzzi G,
Magnol JP. Inherited dystrophic epidermolysis bullosa in
doi: 10.1016/j.jid.2024.04.013 inbred dogs: A spontaneous animal model for somatic gene
83. Chen M, Kasahara N, Keene DR, et al. Restoration of therapy. J Invest Dermatol. 2000;115(1):135-137.
type VII collagen expression and function in dystrophic doi: 10.1046/j.1523-1747.2000.00031-5.x
epidermolysis bullosa. Nat Genet. 2002;32(4):670-675.
94. Jiang QJ, Uitto J. Animal models of epidermolysis
doi: 10.1038/ng1041 bullosa--Targets for gene therapy. J Invest Dermatol.
84. Murauer EM, Gache Y, Gratz IK, et al. Functional correction 2005;124(3):xi-xiii.
of type VII collagen expression in dystrophic epidermolysis doi: 10.1111/j.0022-202X.2005.23652.x
bullosa. J Invest Dermatol. 2011;131(1):74-83.
95. Menoud A, Welle M, Tetens J, Lichtner P, Drögemüller C.
doi: 10.1038/jid.2010.249 A COL7A1 mutation causes dystrophic epidermolysis bullosa
85. Gache Y, Baldeschi C, Del Rio M, et al. Construction of in rotes höhenvieh cattle. PLoS One. 2012;7(6):e38823.
skin equivalents for gene therapy of recessive dystrophic doi: 10.1371/journal.pone.0038823
epidermolysis bullosa. Hum Gene Ther. 2004;15(10):
921-933. 96. Bruckner-Tuderman L, McGrath JA, Clare Robinson E,
Uitto J. Animal models of epidermolysis bullosa: Update
doi: 10.1089/hum.2004.15.921 2010. J Invest Dermatol. 2010;130(6):1485-1488.
86. Bremer J, Kramer D, Eichhorn DS, et al. Murine Type VII doi: 10.1038/jid.2010.75
collagen distorts outcome in human skin graft mouse
model for dystrophic epidermolysis bullosa. Exp Dermatol. 97. Medeiros GX, Riet-Correa F, Barros SS, et al. Dystrophic
2019;28(10):1153-1155. epidermolysis bullosa in goats. J Comp Pathol.
2013;148(4):354-360.
doi: 10.1111/exd.13744
doi: 10.1016/j.jcpa.2012.09.002
87. Liemberger B, Bischof J, Ablinger M, et al. COL7A1 editing
via RNA trans-splicing in RDEB-derived skin equivalents. 98. Nyström A, Buttgereit J, Bader M, et al. Rat model for
dominant dystrophic epidermolysis bullosa: Glycine
Int J Mol Sci. 2023;24(5):4341.
substitution reduces collagen VII stability and shows gene-
doi: 10.3390/ijms24054341 dosage effect. PLoS One. 2013;8(5):e64243.
88. Titeux M, Pendaries V, Zanta-Boussif MA, et al. SIN doi: 10.1371/journal.pone.0064243

Volume 3 Issue 3 (2024) 12 doi: 10.36922/gpd.4047